New FDA guidance on convalescent plasma restricts which COVID-19 patients can receive it
Read full article: New FDA guidance on convalescent plasma restricts which COVID-19 patients can receive itSAN ANTONIO ā Despite the U.S. Food and Drug Administrationās recent update on the use of COVID-19 convalescent plasma, the South Texas Blood and Tissue Center is still encouraging people who are eligible to donate. Some found patients did not benefit from receiving convalescent plasma. āInitially, it was a larger group of patients that could get convalescent plasma. AdThe new recommendations say hospitals should use convalescent plasma with high levels of COVID-19 antibodies before a patient is intubated or placed on a ventilator. Weāre learning so much, and thereās this thirst for finding the best therapies for patients,ā Gomez said.